Patents by Inventor Toby Sommer

Toby Sommer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amphiphilic compositions and methods for preparing and using same
    Patent number: 9096630
    Abstract: The invention relates to amphiphilic C-glycoside derivatives, to methods of using them and to processes for synthesizing them. Specifically, the invention relates to novel cyclic and linear enone-glycolipids and cyclic ketone-glycolipids.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: August 4, 2015
    Assignee: Yale University
    Inventors: Patrick Foley, Paul Anastas, Toby Sommer
  • Amphiphilic Compositions and Methods for Preparing and Using Same
    Publication number: 20120225832
    Abstract: The invention relates to amphiphilic C-glycoside derivatives, to methods of using them and to processes for synthesizing them. Specifically, the invention relates to novel cyclic and linear enone-glycolipids and cyclic ketone-glycolipids.
    Type: Application
    Filed: November 8, 2010
    Publication date: September 6, 2012
    Applicant: Yale University
    Inventors: Patrick Foley, Paul Anastas, Toby Sommer
  • Compositions for treating and/or preventing diseases characterized by the presence of metal ions
    Patent number: 7595308
    Abstract: The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some cases, the composition may include a silanol, a silandiol, a silantriol, or a cyclic organosilane, and/or be able to form a silanol, a silandiol, or a silantriol upon exposure to physiological conditions such as are found in the blood, in the stomach and/or gastrointestinal tract, or in the brain or other organ. In certain cases, the organosilicon compound may be bound to a moiety able to be transported across the blood-brain barrier into the brain, for example, an amino acid, a peptide, a protein, a virus, etc. The organosilicon compound may also be labeled (e.g., fluorescently or radioactively) in certain instances.
    Type: Grant
    Filed: May 17, 2005
    Date of Patent: September 29, 2009
    Assignee: GrenPharma LLC
    Inventors: Orrie Friedman, Ivan Correia, Toby Sommer, David Alan Kew
  • Compositions for treating and/or preventing diseases characterized by the presence of metal ions
    Publication number: 20060040897
    Abstract: The present invention generally relates to the treatment and/or prevention of Alzheimer's disease, other neurodegenerative diseases, and/or diseases characterized by the presence of certain metal ions, by using certain compositions including organosilicon compounds. A composition of the invention may be administered to a mammal, such as a human. In some cases, the composition may include a silanol, a silandiol, a silantriol, or a cyclic organosilane, and/or be able to form a silanol, a silandiol, or a silantriol upon exposure to physiological conditions such as are found in the blood, in the stomach and/or gastrointestinal tract, or in the brain or other organ. In certain cases, the organosilicon compound may be bound to a moiety able to be transported across the blood-brain barrier into the brain, for example, an amino acid, a peptide, a protein, a virus, etc. The organosilicon compound may also be labeled (e.g., fluorescently or radioactively) in certain instances.
    Type: Application
    Filed: May 17, 2005
    Publication date: February 23, 2006
    Inventors: Orrie Friedman, Ivan Correia, Toby Sommer, David Kew